• 2026.02.13Financial Statements
  Non-consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)(194KB)
• 2026.02.12Timely Disclosure
  Announcement of Additional Grant for Program for Promoting Platform for Drug Discovery and Medical Technology Development – Project for Implementation of Innovative Cancer Medicine from the Japan Agency for Medical Research and Innovation(152KB)
• 2026.02.12Timely Disclosure
  Announcement of the Conclusion of XPRIZE Healthspan Clinical Trial Agreement (CTA) with the King Abdullah International Medical Research Center (KAIMRC) in Saudi Arabia(245KB)
• 2026.02.10Timely Disclosure
  Flash Report of a Phase II Clinical Trial of RS5614 in Combination with Paclitaxel for Cutaneous Angiosarcoma(231KB)
• 2026.02.04Timely Disclosure
  Safety Confirmation Test for the PAI-1 Inhibitor RS5614 in Dogs and Cats(192KB)

IR News List